Target Audience:

This webcast is directed primarily to oncologists, registered nurses, physician assistants, nurse practitioners and pharmacists interested in new developments for treatment of non-small-cell lung cancer (NSCLC).

Program Overview:

This series of webcasts is intended to improve care of patients with NSCLC by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of molecular profiling and personalized therapies at various stages of clinical development will be given significant focus. These enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.